viewErgomed PLC

Ergomed jumps following acquisition drug safety firm of Ashfield Pharmacovigilance

The acquisition will add over 40 new clients to Ergomed's roster as well as contracted revenues worth around US$9.8mln

Ergomed PLC - Ergomed jumps following acquisition of Ashfield Pharmacovigilance Inc

Ergomed PLC (LON:ERGO) shares were on the up on Monday as the firm said it has purchased US drug safety firm Ashfield Pharmacovigilance from UDG Healthcare PLC (LON:UDG) for US$10mln.

The AIM-listed pharmaceutical services firm will make Ashfield part of its PrimeVigilence division while also establishing a platform for a “broader Ergomed services business in the US”.

WATCH: Ergomed nets significant new acquisition

Ashfield will add over 40 new clients to Ergomed’s roster as well as an order book on contracted revenues worth US$9.8mln. The acquisition is also expected to immediately enhance earnings.

Ergomed added that the acquisition is expected to “drive economies of scale” as prior investments and support functions are leveraged within its existing PrimeVigilence business.

In the year to 30 September, Ashfield reported revenues of US$11.6mln and adjusted earnings (EBITDA) of US$900,000.

The acquisition is to be funded using the company’s existing cash resources and is not expected to affect its ability to make more purchases thanks to the “strong positive cash flow” from its existing order book.

"The acquisition of Ashfield PV is a major step forward for Ergomed in the strategically important US market. It provides a significant US pharmacovigilance presence and access to a genuinely global offering for customers”, said Ergomed executive chairman Miroslav Reljanović.

“It also strengthens the US platform for the Ergomed CRO business as we continue our drive towards becoming a leading mid-tier pharmaceutical services specialist with a global presence”, he said.

In a note to clients, analysts at Peel Hunt said Ashfield was a “long-established and respected provider in the pharmacovigilance service sector” and the acquisition would be “mutually beneficial” for both Ergomed and UDG.

Ergomed’s shares were 6.2% higher at 414p in early afternoon trading.

Quick facts: Ergomed PLC

Price: 430 GBX

Market: AIM
Market Cap: £205.36 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ergomed PLC named herein, including the promotion by the Company of Ergomed PLC in any Content on the Site, the Company receives from said...



Full interview: Ergomed nets significant new acquisition

Ergomed's (LON:ERGO) CFO Richard Barfield gives Proactive London the full story on the Ashfield PV acquisition, explaining why it's a great fit for Ergomed. News here to on a strong order book and significant new business driving the first-half performance of his company.  Revenues grew...

1 week, 5 days ago

2 min read